
Japanese medicine producer Fujifilm Diosynth Biotechnologies (FDB) has made another investment in its factory in Hillerød, Denmark. This time, it has spent DKK 11bn (USD 1.5bn), Danish financial daily Børsen reports.
FDB will use the investment to expand the factory, which it bought from US-based Biogen in 2019 for DKK 6bn (USD 841m), expecting to hire 450 new people in connection with the expansion.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app